Collegium Pharmaceutical, Inc. - Common Stock —— 资产负债表 (NASDAQ:COLL) | MetaTrader

展开完整图表完整图表

Financials

概览声明统计

每季度年度

总资产 643.84 M692.08 M1.17 B1.14 B1.66 B1.66 B 负债总额 457.81 M489.15 M979.29 M947.88 M1.43 B1.36 B 权益总额 186.03 M202.93 M194.84 M195.43 M228.84 M301.68 M 负债及股东权益总额 643.84 M692.08 M1.17 B1.14 B1.66 B1.66 B 总债务 257.09 M249.99 M700.95 M667.17 M852.49 M809.33 M 净债务 82.97 M63.56 M527.26 M280.29 M595.53 M267.22 M

新闻

Collegium Pharmaceutical (COLL) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Collegium Pharmaceutical (COLL) Q1 Earnings and Revenues Beat Estimates

Earnings Preview: Collegium Pharmaceutical (COLL) Q1 Earnings Expected to Decline

Collegium Pharmaceutical, Inc. (COLL) Discusses Acquisition of AZSTARYS to Expand ADHD Portfolio and Accelerate Growth - Slideshow (NASDAQ:COLL) 2026-03-24

Collegium Pharmaceuticals: Another M&A Episode Adds To An Intriguing Case (NASDAQ:COLL)

Collegium Pharmaceutical, Inc. (COLL) Discusses Acquisition of AZSTARYS to Expand ADHD Portfolio and Accelerate Growth Transcript

Collegium Pharmaceutical, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:COLL) 2026-03-01

Collegium Pharmaceutical (COLL) Reports Q4 Earnings: What Key Metrics Have to Say

Collegium Pharmaceutical (COLL) Q4 Earnings and Revenues Miss Estimates

Collegium Q4 2025 slides: ADHD drug surges despite earnings miss

Collegium PharmaceuticalQ4每股收益及营收逊于预期

Collegium Pharmaceutical earnings missed by $0.10, revenue fell short of estimates